tirzepatide savings program mymounjaro™ & Support Mounjaro Savings Programs vs. Compounded

Tirzepatide's dual GIP/GLP-1 mechanism is particularly effective for PCOS because it directly improves insulin resistance

Healthy Weight Management Support*

PlexusDx sources tirzepatide from licensed 503A compounding pharmaciesnot 503B facilitiesensuring pharmaceutical-grade purity and potency at every dose level

Depending on the individual medicine and its FDA-approved indication, GLP-1 receptor agonists may: Stimulate insulin release when blood glucose is elevated Reduce glucagon secretion Slow stomach emptying Increase feelings of fullness Support lower blood glucose Help some patients reduce body weight Semaglutide is a GLP-1 receptor agonist available in several prescription products

Patients generally eat less and lose weight more consistently when medical treatment is paired with lifestyle changes

However, using compounded GLP-1s carries specific risks: Lack of rigorous testing: Compounded medications are not FDA-approved and have not undergone the same rigorous testing for safety and effectiveness as brand-name drugs